Advertisement
Loading...

Guided Therapeutics, Inc.

GTHP•PNK
Healthcare
Medical - Devices
$0.20
$-0.02(-9.09%)
U.S. Market opens in 11h 5m

Guided Therapeutics, Inc. (GTHP) Stock Overview

Explore Guided Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap15.2M
P/E Ratio-4.64
EPS (TTM)$-0.04
ROE0.82%
Fundamental Analysis

AI Price Forecasts

1 Month$0.28
3 Months$0.40
1 Year Target$0.42

GTHP Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Guided Therapeutics, Inc. (GTHP) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.01, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.42.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.64 and a market capitalization of 15.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-8.26%
3-Month Change
-35.48%
6-Month Change
-15.79%
Year-to-Date (YTD) Change
-62.96%
1-Year Change
90.48%
3-Year Change
17.65%
5-Year Change
-68.75%
All-Time (Max) Change
-43.27%

Contact Information

https://www.guidedinc.com
770 242 8723
5835 Peachtree Corners East, Norcross, GA, 30092

Company Facts

40 Employees
IPO DateJan 8, 2021
CountryUS
Actively Trading

Frequently Asked Questions